Glycoside Hydrolase Inhibitors

Preferred Label : Glycoside Hydrolase Inhibitors;

MeSH definition : Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and APHA-GLUCOSIDASES.; Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES.;

MeSH synonym : Hydrolase Inhibitors, Glycoside; Inhibitors, Glycoside Hydrolase;

MeSH hyponym : Pancreatic alpha-Amylase Inhibitors; alpha-Glucosidase Inhibitors; Intestinal alpha-Amylase Inhibitors; Inhibitors, Pancreatic alpha-Amylase; Pancreatic alpha Amylase Inhibitors; alpha-Amylase Inhibitors, Pancreatic; alpha Amylase Inhibitors, Pancreatic; Inhibitors, Intestinal alpha-Amylase; Intestinal alpha Amylase Inhibitors; alpha-Amylase Inhibitors, Intestinal; Inhibitors, alpha-Glucosidase; alpha Glucosidase Inhibitors; alpha-Glucosidase Inhibitor; Inhibitor, alpha-Glucosidase; alpha Glucosidase Inhibitor;

Wikipedia link : https://en.wikipedia.org/wiki/Alpha glucosidase inhibitors;

Is substance : O;

Details

Origin ID

D065089;

UMLS CUI

C3850174;

ATC code(s)
- alpha glucosidase inhibitors [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
MeSH Descriptor(s) used for indexing
- alpha-Glucosidases [MeSH Descriptor]
Record concept(s)
- Glycoside Hydrolase Inhibitors [MeSH concept]
- Intestinal alpha-Amylase Inhibitors [MeSH concept]
- Pancreatic alpha-Amylase Inhibitors [MeSH concept]
- alpha-Glucosidase Inhibitors [MeSH concept]
See also inter- (CISMeF)
- Product containing alpha-glucosidase inhibitor (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,4-dideoxy-1,4-((2,3,4,5,6-pentahydroxyhexyl)episulfoniumylidene)arabinitol [MeSH Supplementary Concept]
- 13-hydroxykompasinol A [MeSH Supplementary Concept]
- 2,3,4,5,6-pentagalloylglucose [MeSH Supplementary Concept]
- 24,25,26,27-tetranor-apotirucalla-(apoeupha)-1-senecioyloxy-3,7-dihydroxy-14,20,22-trien-21,23-epoxy [MeSH Supplementary Concept]
- 3,5-dimethoxy-4'-O-prenyl-trans-stilbene [MeSH Supplementary Concept]
- 3-O-digalloyl-1,2,4,6-tetra-O-galloylglucose [MeSH Supplementary Concept]
- 4-O-glucopyranosylmoranoline [MeSH Supplementary Concept]
- 5-amino-5-deoxygluconic acid delta-lactam [MeSH Supplementary Concept]
- 6-amino-pyrido(2,3-d)pyrimidine-2,4-dione [MeSH Supplementary Concept]
- 6-aminocyclohex-4-ene-1,2,3-triol [MeSH Supplementary Concept]
- 6-methyl-3-hydroxypiperidine-2-carboxylic acid [MeSH Supplementary Concept]
- 7-deoxycastanospermine [MeSH Supplementary Concept]
- CM-10-18 compound [MeSH Supplementary Concept]
- N-nonyl-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-phenyl-4,5,6,7-tetrachlorophthalimide [MeSH Supplementary Concept]
- acarbose [MeSH Descriptor]
- acarviosine-glucose [MeSH Supplementary Concept]
- acarviosinyl-(1-9)-3-glucopyranosylpropene [MeSH Supplementary Concept]
- butyl isobutyl phthalate [MeSH Supplementary Concept]
- castanospermine [MeSH Supplementary Concept]
- conduritol B [MeSH Supplementary Concept]
- deoxyvalidamine [MeSH Supplementary Concept]
- dihydroacarbose [MeSH Supplementary Concept]
- dihydropyrano(3,2-c)quinoline [MeSH Supplementary Concept]
- dorsilurin F [MeSH Supplementary Concept]
- epigallocatechin-3-O-gallate epigallocatechin dimer [MeSH Supplementary Concept]
- ginnalin A [MeSH Supplementary Concept]
- iso-oenothein C [MeSH Supplementary Concept]
- isoacarbose [MeSH Supplementary Concept]
- jamutannin A [MeSH Supplementary Concept]
- jamutannin B [MeSH Supplementary Concept]
- lamesticumin G [MeSH Supplementary Concept]
- lonchocarpene [MeSH Supplementary Concept]
- miglitol [MeSH Supplementary Concept]
- miglustat [MeSH Supplementary Concept]
- nigrosporamide A [MeSH Supplementary Concept]
- phenyl-6-deoxy-6-(morpholin-4-yl)glucopyranoside [MeSH Supplementary Concept]
- pistagremic acid [MeSH Supplementary Concept]
- polyflavanostilbene A [MeSH Supplementary Concept]
- pradimicin Q [MeSH Supplementary Concept]
- purunuside A [MeSH Supplementary Concept]
- purunuside B [MeSH Supplementary Concept]
- purunuside C [MeSH Supplementary Concept]
- pycnalin [MeSH Supplementary Concept]
- rubasperone A [MeSH Supplementary Concept]
- rubasperone B [MeSH Supplementary Concept]
- salicortin [MeSH Supplementary Concept]
- schulzeine A [MeSH Supplementary Concept]
- scirpusin C [MeSH Supplementary Concept]
- trestatin [MeSH Supplementary Concept]
- valienamine [MeSH Supplementary Concept]
- voglibose [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- Alpha-glucosidase Inhibitor [NCIt concept]
- Alpha-glucosidase inhibitor (disposition) [SNOMED CT concept]
- Alpha-glucoside inhibitor (substance) [Inactive SNOMED CT concept]
- Substance with alpha-glucosidase inhibitor mechanism of action (substance) [SNOMED CT concept]
- alpha glucosidase inhibitors [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients